Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Bourguignon

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 8, 2012
Development of sub-nanomolar dipeptidic ligands of neuropeptide FF receptorsRonan Gealageas, Séverine Schneider, Jean-Paul Humbert, et al.
Mass Spectrometry Reviews|November 2, 2010
Plant organelle proteomics: collaborating for optimal cell functionGanesh Kumar Agrawal, Jacques Bourguignon, Norbert Rolland, et al.
Journal of Medicinal Chemistry|January 25, 2002
Discovery of a 3-amino-6-phenyl-pyridazine derivative as a new synthetic antineuroinflammatory compoundSalida Mirzoeva, Anu Sawkar, Magdalena Zasadzki, et al.
European Journal of Medicinal Chemistry|March 7, 2003
Design, synthesis and structure-activity relationships of a series of 9-substituted adenine derivatives as selective phosphodiesterase type-4 inhibitorsPierre Raboisson, Claire Lugnier, Christian Muller, et al.
The New Phytologist|November 23, 2017
Arabidopsis thaliana plants challenged with uranium reveal new insights into iron and phosphate homeostasisSerge Berthet, Florent Villiers, Claude Alban, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 12, 2013
Synthesis and antiproliferative effects of 5,6-disubstituted Pyridazin-3(2H)-ones designed as conformationally constrained combretastatin A-4 AnaloguesMohamed Elagawany, Martine Schmitt, Adel Ghiaty, et al.
ACS Chemical Neuroscience|September 23, 2014
Structure-activity relationship study around guanabenz identifies two derivatives retaining antiprion activity but having lost α2-adrenergic receptor agonistic activityPhu Hai Nguyen, Hassan Hammoud, Sophie Halliez, et al.
European Journal of Medicinal Chemistry|July 21, 2007
Cyclic nucleotide phosphodiesterase type 4 inhibitors: evaluation of pyrazolo[1,5-a]-1,3,5-triazine ring system as an adenine bioisosterePierre Raboisson, Dominique Schultz, Christian Muller, et al.
ACS Chemical Neuroscience|January 16, 2015
Development of a peptidomimetic antagonist of neuropeptide FF receptors for the prevention of opioid-induced hyperalgesiaFrédéric Bihel, Jean-Paul Humbert, Séverine Schneider, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesiaFrédéric Simonin, Martine Schmitt, Jean-Paul Laulin, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|November 8, 2012
Development of sub-nanomolar dipeptidic ligands of neuropeptide FF receptorsRonan Gealageas, Séverine Schneider, Jean-Paul Humbert, et al.
Mass Spectrometry Reviews|November 2, 2010
Plant organelle proteomics: collaborating for optimal cell functionGanesh Kumar Agrawal, Jacques Bourguignon, Norbert Rolland, et al.
Journal of Medicinal Chemistry|January 25, 2002
Discovery of a 3-amino-6-phenyl-pyridazine derivative as a new synthetic antineuroinflammatory compoundSalida Mirzoeva, Anu Sawkar, Magdalena Zasadzki, et al.
European Journal of Medicinal Chemistry|March 7, 2003
Design, synthesis and structure-activity relationships of a series of 9-substituted adenine derivatives as selective phosphodiesterase type-4 inhibitorsPierre Raboisson, Claire Lugnier, Christian Muller, et al.
The New Phytologist|November 23, 2017
Arabidopsis thaliana plants challenged with uranium reveal new insights into iron and phosphate homeostasisSerge Berthet, Florent Villiers, Claude Alban, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 12, 2013
Synthesis and antiproliferative effects of 5,6-disubstituted Pyridazin-3(2H)-ones designed as conformationally constrained combretastatin A-4 AnaloguesMohamed Elagawany, Martine Schmitt, Adel Ghiaty, et al.
ACS Chemical Neuroscience|September 23, 2014
Structure-activity relationship study around guanabenz identifies two derivatives retaining antiprion activity but having lost α2-adrenergic receptor agonistic activityPhu Hai Nguyen, Hassan Hammoud, Sophie Halliez, et al.
European Journal of Medicinal Chemistry|July 21, 2007
Cyclic nucleotide phosphodiesterase type 4 inhibitors: evaluation of pyrazolo[1,5-a]-1,3,5-triazine ring system as an adenine bioisosterePierre Raboisson, Dominique Schultz, Christian Muller, et al.
ACS Chemical Neuroscience|January 16, 2015
Development of a peptidomimetic antagonist of neuropeptide FF receptors for the prevention of opioid-induced hyperalgesiaFrédéric Bihel, Jean-Paul Humbert, Séverine Schneider, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesiaFrédéric Simonin, Martine Schmitt, Jean-Paul Laulin, et al.
Pageof 9